Ironwood Pharmaceuticals | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Almirall EUR 231.69M 73.09M 2024-06
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amarin USD 16.28M 26.49M 2024-09
Ardelyx USD 97.86M 15.35M 2024-12
Astellas Pharma JPY 382.44B 36.45B 2025-03
AstraZeneca USD 11.35B 819M 2025-03
Charles River Laboratories USD 319.68M 48.09M 2024-12
Exact Sciences USD 500.55M 71.25M 2025-03
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Incyte USD 985.09M 111.22M 2025-03
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
MacroGenics USD 13.86M 94.98M 2024-12
Moderna USD 17M 403M 2025-03
Myriad Genetics USD 150.9M 1.1M 2024-12
Pacira USD 147.37M 17.66M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 526.11M 150.63M 2024-12
Takeda JPY 727.25B 54.48B 2024-12
Ultragenyx Pharmaceutical USD 147.98M 29.51M 2024-12



Ironwood Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.